Antigenic variation of SARS-CoV-2 in response to immune pressure.
Antigenic variation of SARS-CoV-2 in response to immune pressure.
复制标题
DOI:
10.1111/mec.15730
复制
发表时间:
2020-12-02
影响因子:
4.9
通讯作者:
Sironi M
中科院分区:
文献类型:
--
作者:
Forni D;Cagliani R;Pontremoli C;Mozzi A;Pozzoli U;Clerici M;Sironi M
Analysis of the bat viruses most closely related to SARS‐CoV‐2 indicated that the virus probably required limited adaptation to spread in humans. Nonetheless, since its introduction in human populations, SARS‐CoV‐2 must have been subject to the selective pressure imposed by the human immune system. We exploited the availability of a large number of high‐quality SARS‐CoV‐2 genomes, as well as of validated epitope predictions, to show that B cell epitopes in the spike glycoprotein (S) and in the nucleocapsid protein (N) have higher diversity than nonepitope positions. Similar results were obtained for other human coronaviruses and for sarbecoviruses sampled in bats. Conversely, in the SARS‐CoV‐2 population, epitopes for CD4+ and CD8+ T cells were not more variable than nonepitope positions. A significant reduction in epitope variability was instead observed for some of the most immunogenic proteins (S, N, ORF8 and ORF3a). Analysis over longer evolutionary time frames indicated that this effect is not due to differential constraints. These data indicate that SARS‐CoV‐2 evolves to elude the host humoral immune response, whereas recognition by T cells is not actively avoided by the virus. However, we also found a trend of lower diversity of T cell epitopes for common cold coronaviruses, indicating that epitope conservation per se is not directly linked to disease severity. We suggest that conservation serves to maintain epitopes that elicit tolerizing T cell responses or induce T cells with regulatory activity.
登录
查看更多内容
影响因子:
9.8
作者:
Sanjuán R;Nebot MR;Peris JB;Alcamí J
通讯作者:
Alcamí J
影响因子:
28.3
作者:
Gorbalenya, Alexander E.;Baker, Susan C.;Ziebuhr, John
通讯作者:
Ziebuhr, John
影响因子:
64.5
作者:
Andersen KG;Shapiro BJ;Matranga CB;Sealfon R;Lin AE;Moses LM;Folarin OA;Goba A;Odia I;Ehiane PE;Momoh M;England EM;Winnicki S;Branco LM;Gire SK;Phelan E;Tariyal R;Tewhey R;Omoniwa O;Fullah M;Fonnie R;Fonnie M;Kanneh L;Jalloh S;Gbakie M;Saffa S;Karbo K;Gladden AD;Qu J;Stremlau M;Nekoui M;Finucane HK;Tabrizi S;Vitti JJ;Birren B;Fitzgerald M;McCowan C;Ireland A;Berlin AM;Bochicchio J;Tazon-Vega B;Lennon NJ;Ryan EM;Bjornson Z;Milner DA Jr;Lukens AK;Broodie N;Rowland M;Heinrich M;Akdag M;Schieffelin JS;Levy D;Akpan H;Bausch DG;Rubins K;McCormick JB;Lander ES;Günther S;Hensley L;Okogbenin S;Viral Hemorrhagic Fever Consortium;Schaffner SF;Okokhere PO;Khan SH;Grant DS;Akpede GO;Asogun DA;Gnirke A;Levin JZ;Happi CT;Garry RF;Sabeti PC
通讯作者:
Sabeti PC
影响因子:
2.6
作者:
Abduriyim, Shamshidin;Zou, Da-Hu;Zhao, Huabin
通讯作者:
Zhao, Huabin
影响因子:
3.7
作者:
Farrera-Soler, Lluc;Daguer, Jean-Pierre;Winssinger, Nicolas
通讯作者:
Winssinger, Nicolas